M. Lignon

发表

Synthesis and biological activities of some pseudo-peptide analogues of tetragastrin: the importance of the peptide backbone.

J. Bali, R. Magous, B. Castro, 1985, Journal of medicinal chemistry.

Modification of receptor selectivity and functional activity of cyclic cholecystokinin analogues

Jean Martinez, M. Galas, M. Amblard, 1998 .

Pharmacological characterization of new cholecystokinin analogues.

M. Galas, J. Slaninová, L. Maletínská, 1992, European journal of pharmacology.

Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line.

J. Martinez, M. Lignon, N. Bernad, 1993, European journal of pharmacology.

Effect of large targeted deletions on the mitotic stability of an extra chromosome mediating drug resistance in Leishmania.

P. Bastien, C. Ravel, M. Pagès, 2001, Nucleic acids research.

CholecystokininB receptor from human Jurkat lymphoblastic T cells is involved in activator protein-1-responsive gene activation.

M. Le Cunff, E. Cottin, J. Léger, 1997, Molecular pharmacology.

CCK-B receptor activation in human lymphoblastic Jurkat cells results in AP-1 responsive genes activation

E. Cottin, J. Azay, C. Oiry, 2002 .

Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity.

M. Galas, C. Mendre, P. Fulcrand, 1988, The American journal of physiology.

Synthetic CCKS Analogs with Antagonist Activity on Pancreatic Receptors: In Vivo Study in the Rat, Compared to Non‐Peptidic Antagonists

C. Rozé, M. Galas, J. Martinez, 1991, Pancreas.

Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.

M. Galas, C. Mendre, A. Aumelas, 1987, Journal of medicinal chemistry.

A synthetic peptide derivative that is a cholecystokinin receptor antagonist.

M. Galas, A. Aumelas, J. Martinez, 1987, The Journal of biological chemistry.

Synthesis and biological activities of some cholecystokinin analogues substituted in position 29 by a β-alanine

Jean Martinez, M. Galas, A. Aumelas, 2009 .

Synthesis and biological activities of cholecystokinin analogues substituted in position 30 by 3-(1-naphthyl)-l-alanine [Nal(1)] or 3-(2-naphthyl)-l-alanine [Nal(2)]

Jean Martinez, M. Galas, A. Aumelas, 1991 .

Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors.

M. Galas, M. Amblard, A. Aumelas, 2009, International journal of peptide and protein research.

2-Phenylethyl ester and 2-phenylethyl amide derivative analogues of the C-terminal hepta- and octapeptide of cholecystokinin.

M. Galas, A. Aumelas, P. Fulcrand, 2009, International journal of peptide and protein research.

Structure-activity relationships of C-terminal tri- and tetrapeptide fragments that inhibit gastrin activity.

D. Nisato, J. Bali, R. Magous, 1985, Journal of medicinal chemistry.

Pharmacological characterization of type B cholecystokinin binding sites on the human JURKAT T lymphocyte cell line.

J. Martinez, M. Lignon, N. Bernad, 1991, Molecular pharmacology.

Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.

M. Galas, M. Amblard, J. Martinez, 1990, Molecular pharmacology.

Synthesis and biological activity of 2-phenylethyl ester analogues of C-terminal heptapeptide of cholecystokinin modified in Trp 30 region.

M. Galas, A. Aumelas, M. Rolland, 2009, International journal of peptide and protein research.

The role of the Asp-32 residue of cholecystokinin in gastric acid secretion and gastrin receptor recognition

J. Bali, R. Magous, J. Martinez, 1983, Regulatory Peptides.

Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.

M. Galas, C. Mendre, A. Aumelas, 1989, Journal of medicinal chemistry.

A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum.

C. Gueudet, P. Worms, M. Galas, 1988, The Journal of biological chemistry.

On the importance of the peptide bonds in the C-terminal tetrapeptide of gastrin and in the C-terminal heptapeptide of cholecystokinin

Jean Martinez, M. Galas, J. Bali, 1988 .

Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 region.

C. Gueudet, P. Worms, M. Galas, 1990, European journal of pharmacology.

On the significance of the C-terminal primary amide in cholecystokinin

Jean Martinez, M. Galas, M. Rolland, 1993 .

Boc-Tyr(SO3H)-Nle-Gly-Trp-Nle-Asp-2-Phenylethyl Ester — JMV180: A Unique CCK Analogue with Different Actions on High- and Low-Affinity CCK Receptors

J. Martínez, M. Galas, P. Fulcrand, 1991 .

Large and prolonged in vivo response of pancreatic secretion to phenylethylamide and phenylethylester derivatives of Boc-[Nle28-Nle31]CCK(26–33) in the rat

C. Rozé, M. Galas, J. Martinez, 1992, Peptides.

Biological Evaluation of JMV180 Cholecystokinin Analogs

M. Galas, D. Fourmy, M. Amblard, 1994, Annals of the New York Academy of Sciences.

Ac-[3- and 4-alkylthioproline31]-CCK4 analogs: synthesis and implications for the CCK-B receptor-bound conformation.

G R Marshall, G. Marshall, G. Nikiforovich, 1995, Journal of medicinal chemistry.

Correlation between phospholipid breakdown, intracellular calcium mobilization and enzyme secretion in rat pancreatic acini treated with Boc-[Nle28, Nle31]-CCK-7 and JMV180, two cholecystokinin analogues.

M. Galas, J. Martinez, M. Rodríguez, 1990, Cellular Signalling.

Abilities of some tryptophan and phenylalanine derivatives to inhibit gastric acid secretion.

D. Nisato, J. Bali, R. Magous, 1985, Biochimica et biophysica acta.

Pharmacological profile of a new peptidic gastrin antagonist

D. Nisato, J. Bali, R. Magous, 1986, Regulatory Peptides.

Cholecystokinin and gastrin are not equally sensitive to GTP gamma S at CCKB receptors: importance of the sulphated tyrosine.

P. Fulcrand, C. Oiry, J. Martinez, 1995, European Journal of Pharmacology.

Synthesis and characterization of a new labeled gastrin ligand, 125-I-BH-[Leu15]-gastrin-(5-17), on binding to canine fundic mucosal cells and Jurkat cells.

P. Fulcrand, J. Martinez, M. Lignon, 2009, International journal of peptide and protein research.

Cholecystokinin Receptors in Cells of the Immune System

Jean Martinez, M. Lignon, N. Bernad, 1994, Annals of the New York Academy of Sciences.

Molecular cloning and functional expression of a novel human gene encoding two 41-43 kDa skeletal muscle internal membrane proteins.

C. Auffray, M. Le Cunff, J. Léger, 1998, The Biochemical journal.

Receptors that Control Acid Secretion in the Isolated Cells from Mammalian Gastric Mucosa

J. Bali, R. Magous, M. Lignon, 1982 .